Syndax Pharmaceuticals, Inc. (SNDX) Revenue 2016–2025
Syndax Pharmaceuticals, Inc. (SNDX) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$172.4MFY2025 · since FY2016: $1.2M → $172.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $172.4M | +627.8% |
| FY2024 | $23.7M | — |
| FY2023 | $0 | — |
| FY2022 | $0 | -100.0% |
| FY2021 | $139.7M | +9109.6% |
| FY2020 | $1.5M | +0.0% |
| FY2019 | $1.5M | +0.0% |
| FY2018 | $1.5M | -28.0% |
| FY2017 | $2.1M | +72.8% |
| FY2016 | $1.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice